Cardioprotective effects of rutin in rats exposed to pirarubicin toxicity

J Asian Nat Prod Res. 2018 Apr;20(4):361-373. doi: 10.1080/10286020.2017.1394292. Epub 2017 Oct 27.

Abstract

We established both an acute and chronic cardiac toxicity rat model, which showed pretreatment with rutin attenuated pirarubicin-induced myocardial histopathological injury, electrocardiogram abnormalities, and cardiac dysfunction. Rutin also significantly reduced serum levels of MDA, BNP, CK-MB, CTnT, and LDH and increased serum SOD levels. Treatment with rutin and dexrazoxane resulted in an increase in Bcl-2/Bax ratio (p < 0.05) and reduction in JNK and Caspase-3 protein levels, compared to the pirarubicin group (all p < 0.05). Furthermore, rutin at a dose of 50 mg/kg significantly attenuated the above-mentioned alterations. Our study suggests the antioxidant and anti-apoptotic properties of rutin may be responsible for the cardioprotective effects observed.

Keywords: Rutin; anti-apoptotic; antioxidant; cardiotoxicity; pirarubicin.

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Apoptosis / drug effects
  • Cardiotonic Agents / pharmacology*
  • Caspase 3 / metabolism
  • Doxorubicin / analogs & derivatives*
  • Doxorubicin / toxicity
  • Glutathione / pharmacology
  • Lipid Peroxidation / drug effects
  • Male
  • Malondialdehyde / pharmacology
  • Molecular Structure
  • Rats
  • Rutin / chemistry
  • Rutin / pharmacology*
  • Superoxide Dismutase / metabolism

Substances

  • Antioxidants
  • Cardiotonic Agents
  • Malondialdehyde
  • Rutin
  • Doxorubicin
  • pirarubicin
  • Superoxide Dismutase
  • CASP3 protein, human
  • Caspase 3
  • Glutathione